149
Views
16
CrossRef citations to date
0
Altmetric
Research Article

The effect of whole-body hyperthermia combined with 'metronomic' chemotherapy on rat mammary adenocarcinoma metastases

, , &
Pages 103-118 | Published online: 09 Jul 2009

  • Rubens RD. Management of advanced breast cancer. Int J CIin Pract 2001; 55: 676-9.
  • Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990; 50: 6130-8.
  • Fidler IJ. Cancer metastasis. Br Med Bull 1991; 47: 157-77.
  • Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 1972; 175: 409-16.
  • Folkman J, Cole P, Zimmerman S. Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Am Surg 1966; 164: 491-502.
  • Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999; 284: 808-12.
  • Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6.
  • Gasparini G, Bonoldi E, Viale G, Verderio P, Boracchi P, Panizzoni GA, Radailli U, DiBacco A, Gaglielmi RB, Bevilacque P. Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas. Int J Cancer 1996; 69: 205-11.
  • Gately S, Kerbel R. Antiangiogenic scheduling of lower dose cancer chemotherapy. Cancer J 2001; 7: 427-36.
  • Kerbel RS, Viloria-Petit A, Klement G, Rak J. 'Accidental' anti-angiogenic drugs, anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples. Eur J Cancer 2000; 36: 1248-57.
  • Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O'Reilly MS, Folkman S. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 2000; 60: 1878-86.
  • Klement G, Baruchel S, Rak J, Man S, Clark K, Hicklin DJ, Bohlen P, Kerbel RS. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest 2000; 105: R15-24.
  • Clements MK, Jones CB, Gumming M, Daoud SS. Antiangiogenic potential of camptothecin and topotecan. Cancer Chemother Pharmacol 1999; 44: 411-6.
  • O'Leary JJ, Shapiro RL, Ren CJ, Chuang N, Cohen HW, Potmesil M. Antiangiogenic effects of camptothecin analogues 9-amino-20(S)-camptothecin, topotecan, and CPT-11 studied in the mouse cornea model. Clin Cancer Res 1999; 5: 181-7.
  • Napier C, Kaiser R, Collins G, Hcluster B, Chen S-F. Metronomic dosing with Camptosar against human colon tumor xenografts. In: Proc Am Assoc Cancer Res 93rd Annual Meeting, 6-10 April, San Francisco, CA, 2002; 43: 526.
  • Takahashi Y, Mai M. Chemotherapy by combination of low-dose CPT-11 and PSK in an elderly man with liver metastasis from gastric cancer. Gan To Kagaku Ryoho 2001; 28: 531-4.
  • De Cesare M, Zunino F, Pace S, Pisano C, Pratesi G. Efficacy and toxicity profile of oral topotecan in a panel of human tumour xenografts. Eur J Cancer 2000; 36: 1558-64.
  • Sumiyoshi K, Lues N, Strebel FR, Rowe R, Jenkins GN, Bull JMC. The eifert of bolus combined with metronomic administration of Camptosar (CPT-11) in mammary adenocarcinoma lymph node metastases in the rat. In: Proceedings of the 92nd meeting of the American Association for Cancer Research, 24-28 March, New Orleans, LA, 2001; 101.
  • Sakaguchi Y, Makino M, Kaneko T, Stephens L, Strebel F, Danhauser L, Jenkins GN, Bull JMC. Therapeutic efficacy of long-duration, low-temperature whole-body hyperthermia when combined with tumor necrosis factor and carboplatin in rats. Cancer Res 1994; 54: 2223-8.
  • Bull JMC, Loo C, Strebel FR, Jenkins GN, Tomoda M, Rowe R. Treatment of a highly metastatic mammary adenocarcinoma with fever-range, long-duration, low-temperature (40.0°C for 6h) whole-body hyperthermia (LL-WBH) combined with gemcitabine (dFdc) in rats. In: Proceedings of the 90th meeting of the American Association for Cancer Research, 10-14 April, Philadelphia, PA, 1999; 552.
  • Bull JMC, Scott GL, Strebel FR, Nagle V, Koch SM. A phase I trial of fever-range whole-body hyperthermia (LL-WBH) optimally timed with cisplatin (CIS), gemcitabine (GEM) and interferon-a (IFN-a). In: Proceedings of the 93rd Annual Meeting of the American Association of Cancer Research, 6-10 April, San Francisco, CA, 2002; 556.
  • Burd R, Dziedzic TS, Xu Y, Caligiuri MA, Subjeck JR, Repasky EA. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J Cell PAysiol 1998; 177: 137-47.
  • Wondergem J, Strebel FR, Siddik ZH, Newman RA, Bull JM. The effects of anaesthetics on cisplatinum-induced toxicity at normal temperatures and during whole-body hyperthermia: the influence of NaCl concentration of the vehicle. Int J Hyperthermia 1988; 4: 643-54.
  • Lord P, Kapp D, Hayes T, Weshler Z. Production of systemic hyperthermia in the rat. Eur J Cancer Clin Oncol 1984; 20: 1079-85.
  • Wondergem J, Siddik ZH, Strebel FR, Bull JM. Effect of whole body hyperthermia on cisdiamminedichloroplatinum (II)-induced antitumour activity and tissue Pt-distribution: do anaesthetics influence the therapeutic ratio? Eur J Cancer 1993; 29A: 549-54.
  • Wondergem J, Bulger RE, Strebel FR, Newman RA, Travis EL, Stephens LC, Bull JMC. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury. Cancer Res 1988; 48: 440-6.
  • Baba H, Stephens LC, Strebel FR, Siddik ZH, Newman RA, Ohno S, Bull JMC. Protective effect of ICRF-187 against normal tissue injury induced by adriamycin in combination with whole body hyperthermia. Cancer Res 1991; 51: 3568-77.
  • Simmons R, Hoda S, Osborne M. Bone marrow micrometastases in breast cancer patients. Am J Surg 2000; 180: 309-12.
  • Abrams JS. Adjuvant therapy for breast cancer-results from the USA consensus conference. Breast Cancer 2001; 8: 298-304.
  • O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman S. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-85.
  • Slaton JW, Perrotte P, Inoue K, Dinney CP, Fidler IJ. Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule. Clin Cancer Res 1999; 5: 2726-34.
  • Matsuda H, Strebel FR, Kaneko T, Sakaguchi Y, Danhauser LL, Jenkins GN, Bull JMC. Antitumor and normal tissue effects of long-duration, low-temperature whole-body hyperthermia (LL-WBH) combined with doxorubicin (DOX) in rats bearing a highly metastatic mammary adenocarcinoma (MTLnS). In: Proceedings of the 85th meeting of the American Association for Cancer Research, 18-22 March, Toronto, BC, 1995; 1854.
  • Matsuda H, Strebel FR, Stephens LC, Kaneko T, Toyota N, Jenkins GN, Dannhauser LL, Bull JMC. Effect of altered conditions of whole-body hyperthermia +/- doxorubicin on apoptosis and necrosis in a rat mammary adenocarcinoma and normal tissues. In: Proceedings of the 7th International Congress on Hyperthermic Oncology, 9-13 April, Rome, Italy, 1996; 270.
  • Toyota N, Strebel FR, Stephens LC, Matsuda H, Bull JM. Long-duration, mild whole body hyperthermia with cisplatin: tumour response and kinetics of apoptosis and necrosis in a metastatic rat mammary adenocarcinoma. Int J Hyperthermia 1997; 13: 497-506.
  • Ohsiro T, Jenkins GN, Rowe R, Strebel FR, Matsuda H, Nagle V, Bull JMC. Whole-body hyperthermia (WBH) induced vascular endothelial growth factor (VEGF) followed by decreased microvascular density in solid tumors. In: Proceedings of the 89th meeting of the American Association for Cancer Research, New Orleans, USA, 28 March-1 April, 1998; 1854.
  • Tomoda M, Strebel FR, Jenkins GN, Rowe R, Stephens LC, Bull JMC. Microvasculature in the natural progression of lymph node metastasis in a rat breast cancer model: relationship between vascular endothelia growth factor (VEGF) expression, microvessel density, and histopathological findings. In: Proceedings of the 90th meeting of the American Association for Cancer Research, Philadelphia, USA, April 10-14, 1999; 3013.
  • Oshiro T, Jenkins GN, Rowe R, Strebel FR, Matsuda H, Nagle V, BuD JMC. Whole-body hyperthermia (WBH) induced vascular endothelial growth factor (VEGF) followed by decreased microvascular density in solid tumors. In: Proceedings of the 89th meeting of the American Association for Cancer Research, 28 March-1 April, 1998; 1854.
  • Evans SS, Wang WC, Bain MD, Burd R, Ostberg JR, Repasky EA. Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood 2001; 97: 2727-33.
  • Klauber-DeMore N, Van Zee KJ, Linkov I, Borgen PI, Gerald WL. Biological behavior of human breast cancer micrometastases. Clin Cancer Res 2001; 7: 2434-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.